SPI
|
15 987,54
|
201,09
|
1,27%
|
Analysen zu SPI-Werten
| 24.04.24 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Equal Weight | Barclays Capital | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Roche Neutral | UBS AG | |
| 24.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.04.24 | Roche Hold | Jefferies & Company Inc. | |
| 24.04.24 | Roche Outperform | Bernstein Research | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | UBS Outperform | RBC Capital Markets | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | DocMorris Buy | Deutsche Bank AG | |
| 23.04.24 | ABB Hold | Deutsche Bank AG | |
| 23.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 23.04.24 | UBS Underweight | Barclays Capital | |
| 22.04.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.04.24 | ABB Hold | Deutsche Bank AG | |
| 19.04.24 | DocMorris Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 19.04.24 | ABB Sector Perform | RBC Capital Markets | |
| 19.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | Roche Neutral | UBS AG | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | ABB Kaufen | DZ BANK | |
| 18.04.24 | DocMorris Buy | Warburg Research | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 18.04.24 | ABB Market-Perform | Bernstein Research | |
| 18.04.24 | ABB Sector Perform | RBC Capital Markets | |
| 18.04.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.04.24 | DocMorris Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.04.24 | ABB Hold | Jefferies & Company Inc. | |
| 18.04.24 | Givaudan Neutral | UBS AG | |
| 17.04.24 | DocMorris Add | Baader Bank | |
| 17.04.24 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 17.04.24 | DocMorris Buy | Deutsche Bank AG | |
| 17.04.24 | Zurich Insurance Overweight | Barclays Capital | |
| 16.04.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 16.04.24 | DocMorris Buy | Warburg Research |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.